Nov2022-ECDC-WHO-Executive-Summary_Final.pdf
148.6 KB
European Centre for Disease Control: Xmas bundle (Drop 2 of 5)
1) Surveillance of antimicrobial resistance in Europe, 2021 data (WHO Executive Summary)
2) HIV/AIDS surveillance in Europe 2022 (WHO collaborative study)
3) HIV Continuum of care Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia: 2021 progress report
4) Summary of Expert Panel meeting discussions on interventions to increase linkage to care and adherence to treatment for hepatitis B and C, HIV and tuberculosis among people who inject drugs
5) A systematic literature review of interventions to increase linkage to care and adherence to treatment for hepatitis B and C, HIV and tuberculosis among people who inject drugs
1) Surveillance of antimicrobial resistance in Europe, 2021 data (WHO Executive Summary)
2) HIV/AIDS surveillance in Europe 2022 (WHO collaborative study)
3) HIV Continuum of care Monitoring implementation of the Dublin Declaration on partnership to fight HIV/AIDS in Europe and Central Asia: 2021 progress report
4) Summary of Expert Panel meeting discussions on interventions to increase linkage to care and adherence to treatment for hepatitis B and C, HIV and tuberculosis among people who inject drugs
5) A systematic literature review of interventions to increase linkage to care and adherence to treatment for hepatitis B and C, HIV and tuberculosis among people who inject drugs
Supplement-1-List-of-publications.pdf
561.7 KB
European Centre for Disease Control: Xmas bundle (Drop 3 of 5)
1) A systematic literature review of interventions to increase linkage to care and adherence to treatment for hepatitis B and C, HIV and tuberculosis among people who inject drugs Supplement: List of included full text studies, list of excluded full text studies with reason and list of ongoing, withdrawn, and completed studies
2) Interim analysis of COVID-19 vaccine effectiveness against SARS Infection due to SARS-CoV-2 in individuals aged 20 years and older – third update
3) Interim analysis of COVID-19 vaccine effectiveness against SARS Infection due to laboratory-confirmed SARS-CoV-2 among individuals aged 30 years and older, ECDC multi-country study – second update
4) Interim analysis of COVID-19 vaccine effectiveness against SARS Infection due to laboratory-confirmed SARS-CoV-2 among individuals aged 50 years and older, ECDC multi-country study – first update
1) A systematic literature review of interventions to increase linkage to care and adherence to treatment for hepatitis B and C, HIV and tuberculosis among people who inject drugs Supplement: List of included full text studies, list of excluded full text studies with reason and list of ongoing, withdrawn, and completed studies
2) Interim analysis of COVID-19 vaccine effectiveness against SARS Infection due to SARS-CoV-2 in individuals aged 20 years and older – third update
3) Interim analysis of COVID-19 vaccine effectiveness against SARS Infection due to laboratory-confirmed SARS-CoV-2 among individuals aged 30 years and older, ECDC multi-country study – second update
4) Interim analysis of COVID-19 vaccine effectiveness against SARS Infection due to laboratory-confirmed SARS-CoV-2 among individuals aged 50 years and older, ECDC multi-country study – first update
TRP-20211004-1860_0.pdf
726.2 KB
European Centre for Disease Control: Xmas bundle (Drop 4 of 5)
1) Interim analysis of COVID-19 vaccine effectiveness against SARS Infection due to laboratory confirmed SARS-CoV-2 among individuals aged 65 years and older, ECDC multi-country study
2) Interim analysis of COVID-19 vaccine effectiveness in healthcare workers, an ECDC multi-country study, May 2021–July 2022
3) Generic protocol for ECDC studies of COVID-19 vaccine effectiveness against confirmed SARS-CoV-2 using healthcare worker cohorts Version 2.0
4) Supplementary document 1 (for paper 3): Informed consent form
5) Supplementary document 2 (for paper 3): Statistical analysis plan
6) Supplementary document 3 (for paper 3): Guidelines for laboratory testing
1) Interim analysis of COVID-19 vaccine effectiveness against SARS Infection due to laboratory confirmed SARS-CoV-2 among individuals aged 65 years and older, ECDC multi-country study
2) Interim analysis of COVID-19 vaccine effectiveness in healthcare workers, an ECDC multi-country study, May 2021–July 2022
3) Generic protocol for ECDC studies of COVID-19 vaccine effectiveness against confirmed SARS-CoV-2 using healthcare worker cohorts Version 2.0
4) Supplementary document 1 (for paper 3): Informed consent form
5) Supplementary document 2 (for paper 3): Statistical analysis plan
6) Supplementary document 3 (for paper 3): Guidelines for laboratory testing
new-technology-evidence-synthesis.pdf
1.4 MB
European Centre for Disease Control: Xmas bundle (Drop 5 of 5)
1) Use and impact of new technologies for evidence synthesis: Literature review and qualitative data collection
2) Annex 1 (for paper 1): Summary of types of automated technology discussed in the literature
3) Influenza virus characterization Summary report, Europe, September 2022 (in collaboration with the WHO)
4) Communicable Disease Threats Report Week 48, 27 November – 3 December 2022
5) 
1) Use and impact of new technologies for evidence synthesis: Literature review and qualitative data collection
2) Annex 1 (for paper 1): Summary of types of automated technology discussed in the literature
3) Influenza virus characterization Summary report, Europe, September 2022 (in collaboration with the WHO)
4) Communicable Disease Threats Report Week 48, 27 November – 3 December 2022
5)